Earnings Call · Q3 FY2025·2025-11-07

Q3 25EPS +18.52%·Rev n/aQ2 25EPS +3.45%·Rev n/aQ1 25EPS +16.67%·Rev n/aQ4 24EPS +96.25%·Rev n/a⚠ consensus missing

TREACE MEDICAL CONCEPTS, INC. TMCI

Trip Taylor — Investor Relations or Corporate Communications

John Treace — Chief Executive Officer

Mark Hair — Chief Financial Officer

−0.3%1d on move date+0.8% vs SPY3d−43.0%5d−46.8%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TMCI calls or request research access.

More TMCI calls Browse calls Request research access